Nicotinamide

Place Of Origin
CHINA
EINECS
202-713-4
CAS
98-92-0
Assay
99%
Packaging
25kg/drum or as your requirement
Delivery
15 Days

Nicotinamide

Product name: Nicotinamide

CAS: 98-92-0

EINECS: 202-713-4

MF: C6H6N2O

MW: 122.13

Packing: 25kg/drum

Assay: 99%

Usage: Vitamin drugs, metabolic processes in the body, such as for the prevention and treatment of pellagra niacin deficiency.



  • Country: China (Mainland)
  • Business Type:
  • Market:Asia
  • Founded Year:2000
  • Address:湖北省武汉市武昌区中山路496号
  • Contact:qiao peng
*Your name:
*Your Email:
*To:湖北远成赛创科技有限公司
*Subject:
*Message:
Enter between 20 to 3,000 characters. English only.     Characters : 0 / 3000
*Enter the secure code shown below Mfrbee security Image      Reload Image

submiting now We do inquire for you , please wait ...

Nicotinamide riboside chloride 23111-00-4
Nicotinamide riboside chloride 23111-00-4

Use of Nicotinamide riboside chloride Nicotinamide riboside chloride is a crystal form of Nicotinamide riboside (NR) chloride which is a nicotinamide adenine dinucleotide (NAD[+]) precursor vitamin. Nicotinamide riboside chloride increases NAD[+] levels and activates SIRT1 and ...

Hebei Zhaojun New Material Technology Co., LTD

β-Nicotinamide mononucleotide 1094-61-7
β-Nicotinamide mononucleotide 1094-61-7

Use of β-Nicotinamide mononucleotide β-nicotinamide mononucleotide is an intermediate in NAD+ biosynthesis produced from nicotinamide (NAM) and phosphoribosyl pyrophosphate (PRPP) by nicotinamide phosphoribosyl transferase enzyme. Kristy Whatsapp / WeChat/Facebook : +86 ...

Hebei Zhaojun New Material Technology Co., LTD

Factory supply 99.9% β-Nicotinamide Mononucleotide ,NMN ,1094-61-7,NAD+ ,NADP, NADH
Factory supply 99.9% β-Nicotinamide Mononucleotide ,NMN ,1094-61-7,NAD+ ,NADP, NADH

β-Nicotinamide Mononucleotide NMN 1094-61-7 NR NR-CL NAD+ NADP NADH NMN β-Nicotinamide Mononucleotide CAS.1094-61-7 NR Nicotinamide Riboside CAS.1341-23-7 NR-CL Nicotinamide riboside chloride CAS.23111-00-4 NAD+ Nicotinamide adenine dinucleotide CAS.53-84-9 NADP ...

curepharma